Literature DB >> 32388195

Brain functional effects of electroconvulsive therapy during emotional processing in major depressive disorder.

Verena Enneking1, Fanni Dzvonyar1, Kerstin Dück1, Katharina Dohm1, Dominik Grotegerd1, Katharina Förster1, Susanne Meinert1, Hannah Lemke1, Melissa Klug1, Lena Waltemate1, Janik Goltermann1, Carina Hülsmann1, Tiana Borgers1, Joscha Böhnlein1, Lisa Sindermann1, Maike Richter1, Elisabeth J Leehr1, Jonathan Repple1, Nils Opel1, Bernhard T Baune2, Udo Dannlowski1, Ronny Redlich3.   

Abstract

BACKGROUND: In treatment-resistant major depressive disorder (MDD), electroconvulsive therapy (ECT) is a treatment with high efficacy. While knowledge regarding changes in brain structure following ECT is growing, the effects of ECT on brain function during emotional processing are largely unknown.
OBJECTIVE: We investigated the effects of ECT on the activity of the anterior cingulate cortex (ACC) and amygdala during negative emotional stimuli processing and its association with clinical response.
METHODS: In this non-randomized longitudinal study, patients with MDD (n = 37) were assessed before and after treatment with ECT. Healthy controls (n = 37) were matched regarding age and gender. Functional magnetic resonance imaging (fMRI) was obtained twice, at baseline and after six weeks using a supraliminal face-matching paradigm. In order to evaluate effects of clinical response, additional post-hoc analyses were performed comparing responders to non-responders.
RESULTS: After ECT, patients with MDD showed a statistically significant increase in ACC activity during processing of negative emotional stimuli (pFWE = .039). This effect was driven by responders (pFWE = .023), while non-responders showed no increase. Responders also had lower pre-treatment ACC activity compared to non-responders (pFWE = .025). No significant effects in the amygdala could be observed.
CONCLUSIONS: ECT leads to brain functional changes in the ACC, a relevant region for emotional regulation during processing of negative stimuli. Furthermore, baseline ACC activity might serve as a biomarker for treatment response. Findings are in accordance with recent studies highlighting properties of pre-treatment ACC to be associated with general antidepressive treatment response.
Copyright © 2020 The Author(s). Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Biomarker; Depression; Electroconvulsive therapy; Emotional processing; Functional magnetic resonance imaging; Response

Mesh:

Year:  2020        PMID: 32388195     DOI: 10.1016/j.brs.2020.03.018

Source DB:  PubMed          Journal:  Brain Stimul        ISSN: 1876-4754            Impact factor:   8.955


  5 in total

1.  Comparison of Four fMRI Paradigms Probing Emotion Processing.

Authors:  Corinna Hartling; Sophie Metz; Corinna Pehrs; Milan Scheidegger; Rebecca Gruzman; Christian Keicher; Andreas Wunder; Anne Weigand; Simone Grimm
Journal:  Brain Sci       Date:  2021-04-21

2.  Altered voxel-level whole-brain functional connectivity in multiple system atrophy patients with depression symptoms.

Authors:  Hua Guang Yang; Weiyin Vivian Liu; Zhi Wen; Lan Hua Hu; Guo Guang Fan; Yun Fei Zha
Journal:  BMC Psychiatry       Date:  2022-04-20       Impact factor: 3.630

3.  Decreased modular segregation of the frontal-parietal network in major depressive disorder.

Authors:  Zhihui Lan; Wei Zhang; Donglin Wang; Zhonglin Tan; Yan Wang; Chenyuan Pan; Yang Xiao; Changxiao Kuai; Shao-Wei Xue
Journal:  Front Psychiatry       Date:  2022-07-22       Impact factor: 5.435

Review 4.  Current progress in neuroimaging research for the treatment of major depression with electroconvulsive therapy.

Authors:  Xin-Ke Li; Hai-Tang Qiu
Journal:  World J Psychiatry       Date:  2022-01-19

5.  Dynamic Functional Connectivity Predicts Treatment Response to Electroconvulsive Therapy in Major Depressive Disorder.

Authors:  Hossein Dini; Mohammad S E Sendi; Jing Sui; Zening Fu; Randall Espinoza; Katherine L Narr; Shile Qi; Christopher C Abbott; Sanne J H van Rooij; Patricio Riva-Posse; Luis Emilio Bruni; Helen S Mayberg; Vince D Calhoun
Journal:  Front Hum Neurosci       Date:  2021-07-06       Impact factor: 3.169

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.